STOCK TITAN
  1. Home
  2. RXII

RXi Pharmaceuticals Corporation (RXII) Stock Price, News & Analysis

RXII

Company Description

This page collects what Stock Titan holds for RXII, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update

earnings
—

Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting

conferences
—

Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies

clinical trial
—

Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market

offering
—

Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market

private placement
—

Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update

earnings

RXi Pharmaceuticals Corporation has 6 recent news articles. Key topics include earnings, conferences, clinical trial, offering, private placement. View all RXII news →

SEC Filings

View All

No SEC filings available for RXII.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months